Nebula Research & Development LLC Novavax Inc Call Options Transaction History
Nebula Research & Development LLC
- $618 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVAX
# of Institutions
290Shares Held
87.5MCall Options Held
5.13MPut Options Held
8.39M-
Vanguard Group Inc Valley Forge, PA14.1MShares$119 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$100 Million0.0% of portfolio
-
Shah Capital Management9.82MShares$83 Million40.63% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.32MShares$53.5 Million0.08% of portfolio
-
State Street Corp Boston, MA6.07MShares$51.3 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $662M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...